Request Deal Involvement

ARCH Venture Partners led a $400m funding round in Mirador Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

1AB

pr advisors

1AB

Latham & Watkins

legal advisors

Latham & Watkins

or

Principals

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

RTW INVESTMENTS

bidder

RTW INVESTMENTS

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

MIRADOR THERAPEUTICS

target

MIRADOR THERAPEUTICS

ARCH VENTURE PARTNERS

bidder

ARCH VENTURE PARTNERS

LOGOS CAPITAL

bidder

LOGOS CAPITAL

WOODLINE PARTNERS

bidder

WOODLINE PARTNERS

FAIRMOUNT FUNDS MANAGEMENT

bidder

FAIRMOUNT FUNDS MANAGEMENT

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

TCGX

bidder

TCGX

MOORE STRATEGIC VENTURES

bidder

MOORE STRATEGIC VENTURES

BLUE OWL CAPITAL

bidder

BLUE OWL CAPITAL

SANOFI VENTURES

bidder

SANOFI VENTURES

POINT72 VENTURES

bidder

POINT72 VENTURES

BOXER CAPITAL

bidder

BOXER CAPITAL

FARALLON CAPITAL MANAGEMENT LLC

bidder

FARALLON CAPITAL MANAGEMENT LLC

VENROCK HEALTHCARE CAPITAL PARTNERS

bidder

VENROCK HEALTHCARE CAPITAL PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite